Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediBalloon is a medical device development and manufacturing company focused on specialty medical balloons, extrusion tubing, catheter components, and related subassemblies for minimally invasive devices. The company was founded in 2016 in California and built capabilities spanning balloon design, prototyping, pilot production, coating, assembly, and scale-up manufacturing. Its products support a broad set of interventional applications, including cardiovascular, neurovascular, structural heart, peripheral vascular, urology, and general surgery. MediBalloon was acquired by Medeologix in November 2022 and now operates as part of the Medeologix platform, which offers integrated development-to-mass-production services with U.S. and Taiwan manufacturing support. The business is commercial and service-based rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediBalloon.